多发性硬化症:怀孕,生育能力和辅助生殖技术 - - 综述
Celia Oreja-Guevara1, Inés Gónzalez-Suárez2, Mar Mendibe Bilbao3
1Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid (UCM). Madrid, Spain.
Multiple sclerosis and related disorders
|October 11, 2024
概括
多发性硬化症患者可以安全地使用辅助生殖技术 (ART) 怀孕. 早期的计划生育和多学科护理对于管理MS妇女的孕育欲望至关重要.
科学领域:
- 神经学 神经学
- 生殖医学 生殖医学
- 产科 产科 产科 产科 产科
背景情况:
- 对于多发性硬化症 (MS) 患者来说,怀孕是允许的,但由于疾病活动的担忧,怀孕往往会被推迟.
- 在MS患者中延迟受孕可能会影响生育能力,并增加对辅助生殖技术 (ART) 的需求.
研究的目的:
- 为了提供一个全面的,多学科的综述怀孕在多发性硬化症患者.
- 在MS的背景下,解决生育,怀孕管理和ART的关键方面.
主要方法:
- 专家共识会议,涉及神经科医生和妇科医生.
- 英语和西班牙语的PubMed索引文章 (2000-2024) 的系统文献综述.
- 在标题层面审查了354篇文章.
主要成果:
- 审查了男性和女性多发性硬化患者生育能力的证据.
- 研究了怀孕对多发性硬化症病程的影响.
- 分析了MS患者的药物治疗,分娩,母乳养以及各种ART方法 (IUI,试管婴儿,ICSI,卵细胞冷保存).
结论:
- 早期的计划生育和神经病学和妇科病学之间的密切合作对于希望怀孕的多发性硬化症患者至关重要.
- 辅助生殖技术 (ART) 被认为是MS患者的安全和有益,支持精心计划的怀孕.
- 多学科单位在指导多发性硬化症患者的父母之旅中发挥着关键作用.
更多相关视频
相关概念视频
Infertility in Males
253
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
253
In Vitro Fertilization
229
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
229
Infertility in Females
288
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
288
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Spermatogenesis
102.2K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.2K


